Table 3.
Factor | KS patients | Incidence rate, per 100,000 person-years | IRR (95% CI)1 | p-trend1 |
---|---|---|---|---|
Total population | ||||
Ambient UVR tertiles | ||||
T1 (6.0–26.4 mW/m2) | 36 | 8.9 | Ref. | |
T2 (26.5–43.1 mW/m2) | 63 | 12.5 | 1.26 (0.84, 1.92) | |
T3 (43.2–84 mW/m2) | 64 | 16.0 | 1.32 (0.87, 2.02) | 0.22 |
Non-Hispanic white transplant recipients | ||||
Ambient UVR tertiles | ||||
T1 (6.0–26.4 mW/m2) | 21 | 6.6 | Ref. | |
T2 (26.5–43.1 mW/m2) | 32 | 10.0 | 1.53 (0.89, 2.69) | |
T3 (43.2–84 mW/m2) | 20 | 9.3 | 1.18 (0.64, 2.20) | > 0.50 |
| ||||
Skin cancer 2 | KS cases | Controls | OR (95% CI) 3 | p-value 3 |
| ||||
Squamous cell carcinoma | ||||
No | 68 | 1,435 | Ref. | |
Yes | 5 | 25 | 4.83 (1.30, 14.69) | 0.02 |
Basal cell carcinoma | ||||
No | 70 | 1,439 | Ref. | |
Yes | 3 | 21 | 2.95 (0.55, 10.32) | 0.20 |
Melanoma | ||||
No | 72 | 1,458 | Ref. | |
Yes | 1 | 2 | 10.00 (0.17, 192.09) | 0.27 |
Abbreviations: KS, Kaposi sarcoma; IRR, incidence rate ratio; CI, confidence interval; UVR, ultraviolet radiation; T, tertile; OR, odds ratio.
Incidence rate ratios based on Poisson regression after adjustment on sex, race, US citizenship, age at transplant (years), calendar year of transplant, and time since transplant (years). p-trend based likelihood ratio tests treating ordinal UVR categories (1–3) as numeric in regression.
Diagnoses of squamous and basal cell carcinoma were ascertained by the Scientific Registry of Transplant Recipients, while ascertainment of melanoma was based on cancer registry linkages.
Odds ratios based on conditional logistic regression with 20 controls matched to each Kaposi sarcoma case on sex, transplanted organ, age at transplant (±2 years), and calendar year of transplant (±2 years). Restricted to non-Hispanic white transplant recipients. Confidence intervals and p-values based on exact methods.